4D Molecular Therapeutics... (FDMT)
NASDAQ: FDMT
· Real-Time Price · USD
7.28
0.18 (2.54%)
At close: Aug 15, 2025, 3:59 PM
7.23
-0.62%
After-hours: Aug 15, 2025, 07:58 PM EDT
4D Molecular Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 77.16M | 133.53M | 149.34M | 187.54M | 189.06M | 275.59M | 249.11M | 275.68M | 310.34M | 201.86M | 52.35M | 108.3M | 113.48M | 75.97M | 153M | 90.99M | 243.74M | 259.87M |
Short-Term Investments | 216.07M | 187.91M | 275.54M | 314.35M | 352.88M | 250.32M | 39.12M | 43.99M | 74.03M | 121.89M | 161.2M | 119.42M | 127.6M | 160.18M | 94.78M | 70.69M | n/a | n/a |
Long-Term Investments | 123.81M | 137M | 80.58M | 48.78M | 35.72M | 62.94M | 10.95M | n/a | n/a | 1.41M | 4.91M | 11.12M | 20.53M | 48.36M | 67.65M | 65.49M | n/a | n/a |
Other Long-Term Assets | 9.39M | 7.04M | 4.26M | 2.86M | 2.32M | 771K | 684K | 682K | 8.51M | 1.26M | 1.08M | 1.05M | 963K | 875K | 602K | 602K | 602K | 602K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 47K | 791K | 1.22M | 965K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -700K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 10.06M | 11.13M | 10.05M | 8.87M | 10.69M | 9.68M | 8.36M | 8.58M | 7.43M | 6.59M | 6.96M | 4.76M | 5.43M | 6.89M | n/a | 3.27M | 3.79M | n/a |
Total Current Assets | 303.29M | 332.57M | 434.93M | 510.76M | 552.63M | 535.59M | 296.59M | 328.24M | 310.34M | 207.04M | 220.51M | 232.48M | 246.52M | 243.05M | 256.28M | 165.73M | 248.75M | 264.5M |
Property-Plant & Equipment | 37.15M | 39.12M | 40.61M | 41.63M | 29.45M | 30.58M | 31.66M | 32.69M | 33.65M | 34.32M | 35.35M | 35.51M | 34.92M | 32.64M | 28.95M | 8.79M | 5.58M | 5.01M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 170.35M | 183.16M | 125.45M | 93.27M | 67.48M | 94.3M | 43.3M | 33.37M | 42.16M | 36.98M | 41.34M | 47.69M | 56.41M | 81.88M | 97.21M | 74.89M | 6.18M | 5.61M |
Total Assets | 473.64M | 515.73M | 560.38M | 604.03M | 620.12M | 629.88M | 339.89M | 361.61M | 352.5M | 244.02M | 261.85M | 280.16M | 302.94M | 324.93M | 353.49M | 240.62M | 254.93M | 270.11M |
Account Payables | 8.7M | 4.15M | 4.39M | 2.92M | 3.43M | 4.22M | 3.52M | 4.71M | 3.49M | 2.41M | 3.32M | 1.48M | 3.32M | 2.68M | 4.76M | 3.71M | 1.96M | 1.28M |
Deferred Revenue | 1.07M | 866K | 257K | 35K | n/a | 1.32M | 273K | 130K | 576K | 778K | 884K | 2.21M | 2.26M | 2.11M | 2.6M | 1.73M | 3.02M | 7.09M |
Short-Term Debt | 5.72M | n/a | n/a | n/a | 3.2M | n/a | n/a | 3.13M | 3.1M | n/a | n/a | 2.63M | 2.6M | 2.04M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 12.33M | n/a | n/a | n/a | 4.09M | 4.5M | n/a | 1.69M | -968K | n/a | n/a | 900K | 1.27M | 610K | n/a | n/a | n/a | n/a |
Total Current Liabilities | 34.68M | 26.9M | 29.15M | 29.46M | 19.4M | 16.4M | 18.95M | 18.16M | 13.75M | 11.28M | 15.73M | 13.56M | 14.33M | 12.09M | 16.34M | 11.37M | 9.87M | 13.92M |
Long-Term Debt | 17.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 495K | 499K | 603K | 592K | 596K | 600K | 617K | 389K | 236K | 248K | 233K | 236K | 234K | 236K | 334K | 2.1M | 2.08M | 2.08M |
Total Long-Term Liabilities | 18.07M | 19.11M | 20.63M | 21.61M | 12.37M | 12.92M | 13.11M | 13.52M | 13.61M | 14.14M | 14.78M | 15.16M | 16.09M | 16.78M | 18.04M | 5.11M | 4.42M | 13.77M |
Total Liabilities | 52.75M | 46.01M | 49.78M | 51.08M | 31.78M | 29.32M | 32.06M | 31.68M | 725.29M | 25.41M | 30.51M | 28.72M | 30.42M | 28.87M | 34.38M | 16.48M | 14.29M | 27.68M |
Total Debt | 23.08M | 23.85M | 24.61M | 24.83M | 13.66M | 14.17M | 14.67M | 15.16M | 15.63M | 15.68M | 16.12M | 16.55M | 17M | 16.82M | 16.45M | n/a | n/a | n/a |
Common Stock | 5K | 5K | 5K | 5K | 5K | 5K | 4K | 4K | 4K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K |
Retained Earnings | -678.83M | -624.17M | -576.2M | -526.52M | -482.68M | -447.73M | -415.33M | -383.04M | -372.79M | -343.17M | -314.49M | -287.11M | -261.42M | -233.33M | -207M | -181.91M | -159.67M | -152.09M |
Comprehensive Income | 337K | 332K | 229K | 1.08M | -293K | -109K | 16K | 534K | 345K | -270K | -1.2M | -1.85M | -1.83M | -1.42M | -423K | -195K | n/a | 0.00 |
Shareholders Equity | 420.89M | 469.72M | 510.61M | 552.95M | 588.34M | 600.56M | 307.83M | 329.93M | -372.79M | -343.17M | 231.34M | 251.44M | 272.52M | 296.06M | 319.11M | 224.13M | 240.65M | 242.43M |
Total Investments | 347.31M | 324.92M | 356.12M | 363.13M | 388.6M | 313.26M | 50.08M | 43.99M | 74.03M | 123.29M | 166.11M | 130.54M | 148.14M | 208.54M | 162.43M | 136.18M | n/a | n/a |